Silodosin (8mg), Dutasteride (0.5mg) SILODOSIA 8D medications often prescribed in combination for the treatment of benign prostatic hyperplasia (BPH). SILODOSIA 8D is an alpha-1 adrenergic receptor antagonist, and it is used to relax the muscles in the prostate and bladder neck. This helps in improving urine flow and reducing symptoms associated with BPH. SILODOSIA 8D works by blocking the effects of certain neurotransmitters on the smooth muscles of the prostate, leading to relaxation and improved urinary flow. SILODOSIA 8D is a 5-alpha reductase inhibitor. It works by inhibiting the action of the enzyme 5-alpha reductase, which is responsible for converting testosterone into dihydrotestosterone (DHT). DHT is implicated in the enlargement of the prostate. SILODOSIA 8D reducing DHT levels, dutasteride helps to shrink the prostate gland over time, relieving symptoms associated with BPH and reducing the risk of urinary retention. SILODOSIA 8D addresses BPH through complementary mechanisms. Silodosin provides immediate relief of symptoms by relaxing the muscles, while dutasteride works more gradually by reducing the size of the prostate over time. SILODOSIA 8D has been found to be effective in improving symptoms, reducing the risk of acute urinary retention, and decreasing the need for surgical intervention in some cases. Precautions and Considerations: SILODOSIA 8D important to take these medications exactly as prescribed by a healthcare professional. Regular follow-up appointments are typically recommended to monitor the effectiveness of the treatment and assess for any side effects. SILODOSIA 8D and interactions should be discussed with a healthcare provider. SILODOSIA 8D essential for individuals to discuss their specific medical history, symptoms, and any concerns with their healthcare provider before starting or adjusting any medication regimen. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now:https://www.sterisonline.com/product/silodosia-8d-133507